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1  | INTRODUC TION
An increasing number of head and neck cancers (HNC) are attribut‐
able to human papillomavirus (HPV) (Chaturvedi et al., 2011). The 
potential for psychosocial distress and fear of recurrence in HNC 
patients is high (Badr, Gupta, Sikora, & Posner, 2014; Humphris & 
Ozakinci, 2006), due in part to the potential for disfigurement of the 
head and neck region, and dysfunction (e.g., problems with swallow‐
ing, eating) after treatment (Singer et al., 2012). However, identifying 
a sexually transmitted infection as a causal factor may lead to ad‐
ditional distress in patients with HPV‐oropharyngeal squamous cell 
carcinoma (HPV‐OSCC) and their partners (Gold, 2012; Longacre, 
Ridge, Burtness, Galloway, & Fang, 2012; Shuman & Wolf, 2010). 
Common patient concerns related to HPV in HNC have been doc‐
umented to be how, when and why they got their cancer (Fakhry & 
D'Souza, 2013). The answers to these questions are often complex 
and, due to a lack of available evidence, sometimes unanswerable 
(Chu, Genden, Posner, & Sikora, 2013), with implications both for the 
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Abstract
Objective: Increasing numbers of patients face the psychosocial challenge of a diag‐
nosis of oropharyngeal squamous cell carcinoma (OSCC) caused by human papillo‐
mavirus (HPV). We explored the psychosocial impact of an HPV‐OSCC diagnosis for 
patients and their partners.
Methods: In‐depth interviews were conducted with patients (n = 20) and a subset of 
their partners (n = 12), identified through medical records at two UK hospitals. 
Interviews were recorded, transcribed verbatim and analysed using thematic 
Framework Analysis.
Results: Only 12/20 patients interviewed (and five partners) were aware of their 
HPV status and the main analysis focused on this sub‐sample. In discussing the cause 
of their cancer, patients and their partners talked about not wanting to know; whether 
they disclosed the cause of their cancer to others; their reactions to being diagnosed 
with HPV; the prognosis information they were given and the questions they had 
about HPV. Most concerns were cancer‐related rather than HPV‐related, but some 
patients (n = 3) described feelings of embarrassment and perceived stigma about 
HPV.
Conclusion: Some patients and partners who are told HPV is the cause of their OSCC 
have questions about HPV and seek further information. Concerns and uncertainties 
about the sexually transmitted nature of HPV need to be addressed by health 
professionals.
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patient and their past, present or future partners. Partners or carers 
of HNC patients have informational needs independent of those of 
the patients and have fears and concerns about HNC and its conse‐
quences (Richardson, Morton, & Broadbent, 2015).
As patients diagnosed with HPV‐OSCC are typically younger 
than OSCC patients caused by other factors, they will live longer with 
the consequences of treatment (Moschopoulou, Hutchison, Bhui, & 
Korszun, 2018). HPV‐OSCC patients could also be required to man‐
age family life, while dealing with the challenges associated with the 
diagnosis and treatment of their cancer (Gold, 2012). As treatment 
for HNC has been shown to be associated with significant dysfunc‐
tion and disfigurement (De Boer, McCormick, Pruyn, Ryckman, & 
Borne, 1999), HPV‐OSCC patients may need to manage these con‐
sequences of treatment long into survivorship (Moschopoulou et al., 
2018). These patients also seek expedited rehabilitation so that their 
lives can return to normal as quickly as possible (Dodd, Marlow, & 
Waller, 2016). The cervical cancer literature has demonstrated that 
a HPV diagnosis has the potential to cause feelings of stigma and 
shame in addition to the anxiety and health concerns usually asso‐
ciated with abnormal cervical screening results (McCaffery, Waller, 
Nazroo, & Wardle, 2006). Sexual relationships may be affected due 
to concern over the sexual transmission of HPV (Taberna, Inglehart, 
Pickard, Fakhry, & Agrawal, 2017) and clinicians should be prepared 
to potentially talk about these concerns (Reich et al., 2016).
The increasing incidence of HPV‐OSCC worldwide highlights the 
need for research exploring the impact of the diagnosis on patients 
and their partners to enable us to understand the implications of the 
diagnosis. This interview study aimed to explore the psychosocial 
impact of being diagnosed with HPV‐OSCC for both the patient and 
the patient's partner.
2  | METHODS
2.1 | Participants
Eligible patients were identified by medical staff from medical 
records at two UK hospitals. Patients were eligible if: they had 
tested positive for HPV and were at least 1‐year post diagnosis of 
HPV‐OSCC. All patients were eligible to be invited with no limit on 
time since diagnosis. We first invited patients diagnosed closest to 
1 year ago. Partners were eligible if their partner (the patient) met 
the patient inclusion criteria stated above. All participants had to 
be able to communicate in English and be able to give informed 
consent. Ethical approval was granted by South East London NHS 
Research Ethics Committee (Reference: 15/LO/0803).
2.2 | Materials
In‐depth interviews followed a topic guide developed using the 
existing literature on patient experiences of HNC (Lang, France, 
Williams, Humphris, & Wells, 2013; Rapoport, Kreitler, Chaitchik, 
Algor, & Weissler, 1993) and previous qualitative work on HPV and 
cervical cancer (McCaffery et al., 2004; Waller, McCaffery, Nazroo, 
& Wardle, 2005). The topic guide (Table 1) was piloted with mem‐
bers of a participatory advisory group. The interviews began with an 
open question about the participant's experience of diagnosis. The 
rest of the interview was driven by responses to this question, but 
included questions about symptoms, diagnosis, psychosocial impact 
and information needs.
2.3 | Procedure
Patients were invited to participate through an information pack 
sent in the post. The information sheet in the pack informed pa‐
tients that they were being recruited because of their diagnosis 
with HPV‐related head and neck cancer. Patients were asked to 
return a short questionnaire, consent form and contact details 
form using a freepost envelope. A reminder was sent to non‐re‐
sponders after 3 weeks. Partners were sent an information pack 
in the post if patients had indicated on their consent form that 
they were willing for them to be contacted. Signed consent from 
partners was obtained on the day of the interview. Patients could 
participate regardless of whether they had a partner/participating 
partner.
In‐depth interviews were carried out by RD, separately for pa‐
tients and their partners. Interviews took place face‐to‐face (n = 29) 
or by telephone (n = 3) and lasted 26–84 min. They were recorded 
and transcribed verbatim. Emerging themes from the transcripts 
were noted simultaneously with carrying out the interviews. Once 
no new themes had emerged from three consecutive interviews, this 
indicated that saturation had been achieved. Data collection ceased 
at this point (Francis et al., 2010). Information about the subsite of 
patients’ cancer, stage at diagnosis and treatment received was ob‐
tained from their medical records.
2.4 | Analysis
Data were coded thematically using NVivo 11 (QSR, 2015). RD, 
JW and AF read 10% of the transcripts each (n = 3) and developed 
codes independently. All coding was then discussed and disagree‐
ments were resolved before RD coded all of the transcripts. Once 
all the data had been coded in NVivo, it was summarised in a frame‐
work matrix with rows for participants and columns for themes. 
Framework Analysis (Ritchie & Spencer, 1994) was chosen because it 
facilitates comparisons both within and between cases (Gale, Heath, 
Cameron, Rashid, & Redwood, 2013). Patients and partners were all 
treated as separate participant cases in a single framework. LM read 
a further 10% of the transcripts and checked her agreement against 
the coding framework.
3  | RESULTS
3.1 | Sample characteristics
Out of 89 patients sent an information pack, 27 returned a con‐
sent form (30% response rate). Patients (n = 20) and partners 
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(n = 12) were interviewed in September/October 2014 and between 
September and November 2015. Patients average time since diag‐
nosis was 23 months (range 12–53 months). All were diagnosed with 
a primary tumour in the tonsil (n = 14) or base of tongue (n = 5) and 
all except one had late‐stage disease (stage IV A to C). Patients had 
received surgery alone (n = 1), surgery with chemoradiation (n = 5), 
surgery with radiation (n = 5) or radiation only (n = 8). The medical 
records for one patient were not obtainable. The majority of patients 
were male, white British, married or cohabiting, and either employed 
full‐time or retired (see Table 2).
Social grade, education and general health characteristics of the 
recruitment hospitals areas are shown in Table 3 (I Live Here UK, 
2018).
3.2 | Overview
Data were examined to understand the psychosocial impact of 
being diagnosed with HPV‐OSCC, looking at individual experiences 
for both the patient and their partner, and to explore how this var‐
ied between participants. Some initial reactions to being diagnosed 
with cancer included shock, panic, feeling destined for the diagnosis, 
thinking they were going to die, and feeling vulnerable and fright‐
ened. A small number of patients said the diagnosis was not a shock 
and a few of them felt like it was not happening to them.
Twelve patients in the sample were aware of the cause of their 
cancer being HPV, whereas the rest were not. The first theme ex‐
plores causal beliefs across the whole sample and includes discus‐
sion of the information patients received from health professionals 
about the cause of their cancer. Subsequent themes focus on the 
data from the sub‐sample of participants (n = 17; 12 patients, five 
partners) who were aware of the causal role played by HPV in their 
(or their partner's) cancer. These themes include: disclosing HPV to 
others, being diagnosed with HPV, prognosis, and questions and in‐
formation about HPV.
3.3 | Causal beliefs
This theme distinguishes between patients who knew about HPV 
and those that did not. It covers the cause of patients’ cancer and 
whether knowing the cause mattered. Almost a third of patients 
brought up the cause of their cancer and all others discussed it after 
being prompted by the researcher.
3.3.1 | HPV or virus
Some patients were told by their doctor that their cancer was caused 
by HPV (n = 6) or “by a virus” (n = 3). HPV was not always disclosed 
by a doctor as the cause of patients’ cancer, with a couple of patients 
finding out after being approached by a member of a clinical trials 
team asking them about taking part in research and others remained 
unaware of the cause. HPV was not always accepted as the cause of 
cancer, with one partner, after a conversation with her friend who 
was a nurse, dismissing HPV as the cause of her partner's cancer.
TA B L E  1   Interview topic guide—patients
Introduction
• Open with an introduction to self and the study, giving background 
and aims of the study—explain a university study, not the NHS
• Tell the participant how long you expect the interview to take 
(between 30 min to an hour) and explain that the interview will 
be tape recorded
• Explain about confidentiality, and the use of the data
• Explain don't need to talk about anything uncomfortable with and 
no right/wrong answers
• Any questions?
Patient's experience
• Ask about patients experience of being diagnosed—this is an 
open‐ended question to enable the patient to talk freely about 
their experiences
Prompts
Symptoms—Symptom recognition and how long before went to a 
HCP
Disclosing symptoms to anyone
Diagnosis—Who/how/what/when told
Any difficulties/anxieties
Involved in any care/treatment decisions?
Alone or with a partner?
Referred for any support? (counselling needs, QoL, psych 
treatment)
IF HPV mentioned:
What was talked about
How did you feel
IF HPV NOT mentioned:
Did the health professional mention HPV at all?
If so, how did you feel
Psychosocial—Initial feelings
Disclosure to partner/others
Reactions of partner/others
Adjustments/coping/impact on daily life (physical, psychologi‐
cal, social)
Anything to help you cope better?
Changes to relationship?
Effect on others
Feelings about the future
Information needs—any research prior to diagnosis
Amount of information received
Lacking any information?
Look elsewhere for information? If so, where, what helpful/
unhelpful
Were you given any written information? Need for it?
Closing the interview
• Any other comments, issues or suggestions that haven't been raised?
• Thank interviewee
• Reassure about confidentiality
• Give debrief, repeating the aims of the study and leaving details 
of available support
• Ask if happy to be re‐contacted later in the study
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3.3.2 | Other and unknown cause
Some patients were not aware that HPV was the cause of their can‐
cer despite having been tested for it. A patient whose brother‐in‐
law had also been diagnosed with HPV‐OSCC specifically asked his 
doctor if he had HPV and was told he had “been unlucky” and that 
they had not found HPV. Another patient was angry that she had not 
been asked if she wanted a test for HPV.
A number of patients who did not recall being told what the 
cause of their cancer was had searched for a causal attribution; 
some attributed it to smoking, related it to work or genetics. 
Some of these patients expressed the view that they wanted to 
know:
I would have loved, ‘Yeah, that’s what’s caused it.’ But 
to this day, I don’t know what it is. 
 (Male, 56 years, patient)
3.3.3 | Cause doesn't matter
Nearly half of the patients said it did not matter what had 
caused their cancer, the most important thing was that they “got 
rid of it.” The cause was also seen as something that could not 
be changed, “I can't go back and say I'll not do that” (Female, 
66 years, patient) and that it did not affect the treatment. This 
partner expressed her relief that her husband's cancer was now 
gone:
I don’t care how it was caused. It was just that it’s gone, 
we hope, you know.  (Female, 64 years, partner)
3.4 | Disclosing HPV as the cause to others
A couple of patients gave examples of why they thought others did 
not ask them about the cause of their cancer, believing that “the can‐
cer word's enough for most people” (Female, 61 years, patient) and 
“they think well you get cancer and you just get it, it's one of those 
things that happens” (Male, 61 years, patient). Some patients who 
knew that HPV was the cause of their cancer, felt uncomfortable 
talking about it with others: “It's not a conversation you really want 
to have with your daughter” (Female, 58 years, patient). One patient 
described telling people “It's viral, in my throat, very treatable, a type 
of skin cancer, it comes from HPV” and that “you don't go around 
broadcasting that something's sexually transmitted” (Male, 49 years, 
patient).
One of the younger patients said she found it easier to tell other 
people than her partner:
TA B L E  2   Patient and partner characteristics
Patient characteristics (n = 20) Partner characteristics (n = 12)
Age at diagnosis [median (range)] 57 (40–82) /
Time since diagnosis in months [median (range)] 23 (12–52) /
Age at interview [median (range)] 59 (41–83) 60 (45–74)
Sex [n]
Male 14 2
Female 6 10
Ethnicity [n]
White British 19 12
Other 1 /
Marital status [n]
Married/Cohabiting 14 12
Widowed 2 /
Divorced 2 /
Separated 1 /
Single 1 /
Employment status [n]
Employed full‐time 7 1
Employed part‐time 2 5
Unemployed 1 /
Retired 8 5
Disabled or too ill to work 2 1
Knew their/partner's cancer was HPV‐positive [n] 12 5
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When they told me it was because of HPV I don’t 
think I told him for ages … I think it was easier to tell 
other people why as opposed to him. 
 (Female, 41 years, patient)
One partner described how everyone assumes HNC is caused by 
smoking and how people reacted when she and her partner told them 
about HPV. Most of their friends said they looked HPV up on the inter‐
net after they had explained, as they “didn't know that could happen 
or exist.”
Reluctance to discuss HPV as a cause of their cancer with oth‐
ers was evident, not fully disclosing their diagnosis to others and 
viewing it as a “medical thing” so only felt comfortable talking about 
HPV with medical professionals. One patient explained how she felt 
there was “stigma attached to it [HPV],” due to experiencing nega‐
tive reactions from other people and how this prevented her from 
disclosing the cause of her cancer. This patient felt more comfort‐
able talking about HPV after her consultant had told her:
This is the most contagious virus in the world, 95% of 
people manage to disperse it through their immune 
system, 5% don’t and unfortunately, 5% of that 5% it 
turns to cancer and you’re unlucky.
  (Female, 42 years, patient)
Some participants also brought up Michael Douglas (a celebrity 
who openly described HPV and oral sex as the cause of his oral cancer) 
and viewed what he had said as “not helpful” and there was a “sensa‐
tionalist aspect” surrounding the sexually transmitted nature of HPV. 
One partner described how she was happy telling people that her part‐
ner's cancer was caused by HPV before Michael Douglas said that “it's 
caused by oral sex.”
Well, to start with probably I was quite open telling 
people that [name of patient]’s cancer was caused by 
HPV but, after that, a bit more reluctant to discuss it. 
Which is a shame, because I think that more people 
need to be aware of this, but it’s difficult. 
 (Female, 62 years, partner)
3.5 | Being diagnosed with HPV
This theme describes reactions to being diagnosed with HPV and 
preferences for being told about HPV.
3.5.1 | Reactions to being diagnosed with HPV
Patients’ reactions to news of their cancer being caused by HPV 
were embarrassment, confusion, surprise, disappointment, shock 
and feeling unlucky. One patient described how she had “got a little 
bit of an issue still with it” and how her husband had “said something 
that made me feel really dirty” (Female, 42 years, patient).
One patient explained how she was embarrassed about the HPV 
aspect of her cancer, but how it feels less relevant now, with the 
cancer being most important, not the cause. Transmission of HPV to 
their partner was a concern for some patients and one of the part‐
ners decided to get tested privately for HPV.
3.5.2 | When and how to be told about HPV
There were mixed opinions from patients about when would be the 
best time to have been told about HPV as the cause of their cancer. 
Patients recognised that the initial diagnosis stage might not be the 
best time, but other participants thought it would have been helpful 
TA B L E  3   Recruitment hospitals area characteristics (I Live Here 
UK, 2018)
Hospital 1 (%) Hospital 2 (%)
Social gradea
AB 16 28.6
C1 32.4 37.4
C2 16.4 15.1
DE 35.2 18.9
Educationb
No qualifications 28.7 16.1
Level 1 12.5 11
Level 2 14.2 12.6
Apprenticeship 2.5 2.1
Level 3 15.2 16
Level 4 22.4 36.9
Other 4.4 5.4
General health
Very good 46.7 49.3
Good 30.5 33.6
Fair 14 11.8
Bad 6.7 4.1
Very bad 2.1 1.2
aSocial grade: AB Higher & intermediate managerial, administrative, pro‐
fessional occupations; C1 Supervisory, clerical & junior managerial, ad‐
ministrative, professional occupations, C2 Skilled manual occupations; 
DE Semi‐skilled & unskilled manual occupations, Unemployed and low‐
est grade occupations bEducation: Level 1 (1–4 O Levels/CSE/GCSEs 
(any grades), Entry Level, Foundation Diploma, NVQ Level 1, Foundation 
GNVQ, Basic/Essential Skills); Level 2 (5+ O Level (Passes)/CSEs (Grade 
1)/GCSEs (Grades A*‐C), School Certificate, 1 A Level/2–3 AS Levels/
VCEs, Intermediate/Higher Diploma, Welsh Baccalaureate Intermediate 
Diploma, NVQ level 2, Intermediate GNVQ, City and Guilds Craft, BTEC 
First/General Diploma, RSA Diploma; Level 3 (2+ A Levels/VCEs, 4+ AS 
Levels, Higher School Certificate, Progression/Advanced Diploma, 
Welsh Baccalaureate Advanced Diploma, NVQ Level 3; Advanced 
GNVQ, City and Guilds Advanced Craft, ONC, OND, BTEC National, RSA 
Advanced Diploma); Level 4 (Degree, Higher Degree, NVQ Level 4–5, 
HNC, HND, RSA Higher Diploma, BTEC Higher level, Foundation degree 
(NI), Professional qualifications; Other (Vocational/Work‐related 
Qualifications, Foreign Qualifications (not stated/level unknown). 
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and honest to know at the beginning, when they were first told their 
diagnosis.
This patient also described how she was told about HPV and how 
this was not how she believes she should have been told:
When I found out I had it because of HPV … how it 
just came out totally at random … to me, if you are 
gonna be told something like that, which psycholog‐
ically becomes very relevant, it would have probably 
been better to have known in a proper way not just a 
chat.  (Female, 41 years, patient)
3.6 | Prognosis of HPV‐related cancers
Most of the patients given information about their prognosis were 
told that it was treatable, curable and they could expect to recover 
completely. The statistics given to patients ranged from 50% to 85% 
survival, with research showing higher survival rates for HPV‐related 
diagnoses. Patients were reassured by the better prognosis given to 
HPV‐related diagnoses and one patient described how he focused 
on the words “it's treatable” (Male, 56 years, patient).
One patient interpreted 80% survival as good, but then trans‐
lated this into real life and how many do not survive, when he saw 
the radiotherapy masks lined up in the room.
She [radiographer] said, we’ve got 42 masks at the 
moment. And I’ll tell you what kicked in then, there’s 
eight of us not going to make it then. That is what was 
in my mind.  (Male, 53 years, patient)
3.7 | Questions and information about their cancer
The final theme related to information patients and their partners 
were given about HPV, their information demands and information 
seeking behaviours.
3.7.1 | Understanding of HPV
Participants were given different information about HPV. Most 
participants had never heard of HPV before they were diagnosed. 
Those that were already aware of HPV tended to be women who had 
heard about it in the context of cervical cancer. Patients described 
discussing HPV in relation to cervical cancer and that “the HPV virus 
is in all of us.”
Some of the understanding about HPV that participants came 
away with following consultations were that it is “a virus,” is “sexually 
transmitted,” and “seems to affect anybody,” “you could have had it 
for years,” it is “the most contagious virus in the world,” “it's on the 
increase” and is “becoming more and more common in all ages.”
Questions participants had about HPV included whether HPV is 
likely to travel around their body, “what's the chance of it coming back,” 
“where has this [HPV] come from,” “how's it taken so long to come 
through,” have they still got HPV, “is it only sexually transmitted,” how 
long have they been carrying HPV, what is the prognosis, will the treat‐
ment get rid of HPV and are their children more at risk of HPV.
One patient was reassured by a friend who works in a hospital, 
that people's beliefs about HPV being down to oral sex, “is their na‐
ivety.” One patient believed that there were ways, other than oral 
sex, that HPV could be transmitted:
I mean surely if you can transmit the virus around, 
there’s going to be other ways of doing it as well, 
surely? It could be a cut on your hand, it could be a 
kiss, it could be anything, couldn’t it really? You just 
don’t know really.  (Male, 59 years, patient)
Searching for information about HPV
Although the internet was a popular source of information for par‐
ticipants, there was an understanding that searching the internet 
should be done with caution. A few did not want to look for any more 
information on the internet because they did not want to “panic” or 
read the wrong information:
No. I never look on the Internet for anything like that 
... it’s no disrespect to anyone who put it on there, but 
they don’t know like the professionals.
  (Male, 59 years, patient)
Some patients looking for more information found confirmation 
of what their doctor had told them. The internet was used to look 
for general information on HPV, information about the best treat‐
ment options, to research symptoms, causes, information about their 
doctor, explanations of tests and for further information about their 
particular cancer. One patient described how she “broke down” after 
looking up HPV on the internet as all the information said it was all 
because of oral sex.
For those that did further research into HPV, the level of research 
undertaken varied. One partner read research papers on HPV:
It seemed like the chances of recurrence were pretty 
low after the sort of standard treatment, which was 
what [name of patient] had had. So I was pretty reas‐
sured by that.  (Female, 62 years, partner)
Some participants felt the information currently available was not 
applicable to them. One patient noted that information about HPV 
seems to be “centred on teenagers” and was “either aimed at young 
people not contracting HPV or old people not getting cancer through 
HPV” (Female, 41 years, patient). This particular patient felt like the 
information available about throat cancer was aimed at “that sort of 
age group—60 plus. And you are like, well, that's not me.” There were 
a number of participants who were satisfied with the amount of infor‐
mation they had been given.
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Keeping others informed
The importance of keeping the family informed about how the 
patient was, was recognised, but was described by one partner as 
“emotionally draining” (Female, 49 years, partner). Some partners 
found keeping people up‐to‐date was tiring, having to answer peo‐
ple's texts and phone calls. One partner adopted a strategy of email‐
ing everyone to keep them updated at once.
3.7.2 | Need for more research
It was acknowledged that there was a need for more research about 
HPV‐OSCC and that this was expected in a few years’ time. Also, 
that further research may lead to different and “milder treatment” 
for HPV cancer, with this one partner hoping this would mean peo‐
ple “wouldn't have had to go through the dramatic treatment he did 
have to go through” (Female, 62 years, partner).
3.7.3 | Feelings about the future
Most of the patients and their partners were positive about the fu‐
ture, but fear of recurrence was common among patients and their 
partners. This was sometimes related to HPV, such as this patient 
wondering “is it [cancer] more likely to come back because of this 
[HPV]? Is it something that stays in your body?” (Female, 61 years, 
patient).
4  | DISCUSSION
This study explored the psychosocial impact of being diagnosed with 
HPV‐OSCC for patients and their partners. Although the medical re‐
cords of all patients showed their tumour was HPV‐positive, not all 
patients were aware of this. This suggests a need for better informa‐
tion provision to ensure greater understanding of HPV in this patient 
group. Reactions were mixed among those who knew their cancer 
was caused by HPV. Some participants felt embarrassed and felt that 
there was a stigma associated with HPV. Other participants were not 
concerned about the cause of their cancer and were more interested 
in knowing that survival rates for a diagnosis of HPV‐OSCC were 
better than for non‐HPV HNCs, suggesting concerns were more 
cancer‐related than HPV‐related. Patients and partners who were 
told that HPV was the cause of their cancer had a number of ques‐
tions about HPV and some sought further information. Psychosocial 
effects were similar to those described in previous qualitative re‐
search with HNC patients (Baxi et al., 2012; De Boer et al., 1999; 
Lang et al., 2013), with patients describing times of depression, anxi‐
ety and denial, but also feelings of optimism and relief.
Participants’ reactions to finding out that their HNC was caused 
by HPV varied. In line with findings from the cervical cancer liter‐
ature, some patients reported feelings of embarrassment, confu‐
sion and concerns of transmission to their partner (McCaffery et 
al., 2006). Michael Douglas openly telling the media that “oral sex 
caused my cancer” (Shoard, 2013), was also noted to have added a 
“sensationalist aspect” to HPV‐OSCC. This had rendered one partner 
less inclined to be open about the diagnosis, while others described 
giving factual information about HPV being the cause when dis‐
cussing with others, suggesting they were trying to avoid attaching 
stigma to it. Given that for some participants, the survival benefits 
seemed to outweigh psychosocial issues related to the sexual na‐
ture of HPV‐OSCC, this suggests that placing emphasis on survival in 
consultations and the media could help alleviate stigma surrounding 
the diagnosis of HPV‐OSCC.
One key message about HPV suggested in a previous study of 
health professionals (Dodd et al., 2016) was the importance of nor‐
malising HPV. Consistent with this, patients in this study reported 
health professionals using the link between HPV and cervical cancer 
to normalise HPV and emphasised telling them it is becoming more 
and more common. Some participants did search for more informa‐
tion about HPV and described how the information available was not 
always applicable to them and was targeted at young girls in relation 
to the HPV vaccination. Information sought by patients and their 
partners about HPV was about where HPV had come from, possi‐
ble transmission and future HPV risk, supporting previous research 
which showed from a sample of 62 HPV‐OSCC patients, 18% sought 
causal information, 15% sought information about vaccinations, 10% 
about prevention of transmission and 10% about available treatments 
(Milbury, Rosenthal, El‐Naggar, & Badr, 2013). The internet was a pop‐
ular source of information for participants, consistent with previous 
studies (Baxi et al., 2012) although patients did recognise that informa‐
tion on the internet is not always trustworthy and reliable. Searching 
for information also elicited differing reactions, with some patients 
finding the suggestion that oral HPV was transmitted through oral 
sex distressing, whereas other participants found information about 
the better prognosis, reassuring. Findings from a previous study with 
a similar population showed patients wanted more information about 
HPV and that “a cohesive, comprehensive, and trusted source would 
be valuable” (Baxi et al., 2012) (p5). These findings suggest that there 
is a need for information about HPV and HNC to be tailored for pa‐
tients with HPV‐OSCC and developed in line with evidence‐based 
research. An information and support package for patients and their 
partners seeking information could help alleviate anxiety relating to 
HPV. There is a need for clear and consistent health messages aimed 
at diminishing stigma, fear and self‐blame (Daley et al., 2010).
Previous research in the USA has confirmed that less than half of 
oncologists discuss HPV with their patients (Milbury et al., 2013) and 
this study showed just over half of patients were aware of their HPV 
diagnosis. As it is becoming more recognised that patients should be 
informed that HPV is the cause of their cancer (Shuman & Wolf, 2010), 
health professionals need to decide on the best time to discuss this with 
patients, with patients in this study suggesting the earlier the better.
Previous research with a small sample of male HPV‐OSCC sur‐
vivors also found that HPV was often overshadowed by the cancer 
itself and that patients were encouraged by the positive prognosis 
(Baxi et al., 2012). Similarly, a previous study showed that although 
information about HPV was seen as relevant, it was considered sec‐
ondary to concerns about treatment of their cancer (Low et al., 2009).
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Partners were often the source of information for others, being 
the ones to keep the wider family informed about the patient. 
Partners also sought information about HPV and other aspects of 
their partners’ cancer, in the effort to be as prepared as they could 
be, supporting previous findings from a study in New Zealand with 
73 caregivers that found caregivers requested information, in an ef‐
fort to improve their understanding of the situation (Richardson et 
al., 2015). Partners also thought about others, trying to hide their 
feelings from either the patient or the rest of their family. Unlike 
previous studies (Baxi et al., 2012; Low et al., 2009; Manne & Badr, 
2008), no patients or partners in this study reported decreases in 
intimacy, but this may be because they were not specifically probed 
about their sexual relationships, but asked if there had been any 
changes to their relationship.
4.1 | Strengths and limitations
This study is the first in the UK to interview patients diagnosed with 
HPV‐OSCC, as well as their partners. Qualitative interviews give 
a greater depth of data than questionnaires to provide an under‐
standing and description of people's personal experiences. By inter‐
viewing patients and partners separately, we enabled each to share 
experience from their own perspective without being influenced by 
their partner, although it is possible that patients and their partners 
may have discussed the interview before participating. Interviewing 
both patients and their partners also allowed HPV to be discussed, 
which may have been too sensitive to bring up in joint interviews. 
Our sample of patients who were aware of their HPV status was 
small, so HPV was not discussed in some interviews, thereby limit‐
ing their scope. The response rate of 30% may have also limited the 
responses and our participants may not be representative of all pa‐
tients diagnosed with HPV‐OSCC due to their recruitment from two 
UK hospitals. However, these two hospitals enabled us to sample 
from areas of different socioeconomic status and education levels 
and so may provide a broader representation than two hospitals in 
the same area of the UK. Participants were probed about changes 
to their relationship, but not specifically about their sexual relation‐
ships, which on reflection would have been important to discuss 
with this sample.
5  | CONCLUSION
This study suggests that HPV‐OSCC has a significant psychosocial 
impact on patients and their partners, but that most concerns are 
related to dysfunction following cancer treatment and not to their 
HPV status. However, there are concerns and uncertainties about 
the sexually transmitted nature of HPV which could easily be ad‐
dressed in information from a trustworthy and reliable source such 
as the patient's doctor. Participants in this study were ill informed 
and unaware regarding HPV, therefore written information for pa‐
tients and their partners is also likely to be a useful resource which 
could be discussed around the time of diagnosis.
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